News Focus
News Focus
icon url

Whalatane

10/08/25 7:43 PM

#1913 RE: Fred Kadiddlehopper #1912

Fred , he's just making the rounds ...fishing so to speak .
Also appeared on the AMLX board



Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) as securities fraud class action survives a motion to dismiss. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) prior to May 11, 2023, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.
Please visit https://grabarlaw.com/the-latest/amylyx-shareholder-investigation/, contact Joshua Grabar at jgrabar @chonpz.

https://stockhouse.com/news/press-releases/2025/10/07/important-notice-to-long-term-shareholders-of-amylyx-pharmaceuticals-inc-amlx



Kiwi
icon url

ErnieBilco

10/08/25 8:08 PM

#1914 RE: Fred Kadiddlehopper #1912

Some other tickers I had from time to time according to his post history, mostly 1 and done he's obviously not a hard worker.